Sermorelin cas 86168-78-7

Sermorelin, also known as GHRH (1-29), is a growth hormone-releasing hormone (GHRH) analogue used as a diagnostic agent. It is a 29-amino acid polypeptide representing the 1–29 fragment from endogenous human GHRH, and is thought to be the shortest fully functional fragment of GHRH.[1] It is used as a diagnostic agent to assess growth hormone (GH) secretion. It is also used as doping agent in sports due to its correlation with increased growth of muscular and skeletal tissue.[citation needed] Sermorelin use is also hypothesized to improve deep rapid eye movement sleep.

Properties:

Appearance & Physical State: White powder

Density: 1.45 g/cm3

Refractive Index: 1.649

Related Prodcuts:

Dynorphin A (1-13); Deslorelin; Gonadorelin; Gonadorelin acetate; Sermorelin Acetate; Etelcalcetide; DSIP; Lixisenatide; Angiotensin acetate; Epithalone; Buserelin; Cilengitide; Cilengitide trifluoroacetate; Tesamorelin; Selank; ACTH (1-39) Seractide; Ipamorelin

1: Knoop A, Thomas A, Fichant E, Delahaut P, Schänzer W, Thevis M. Qualitative identification of growth hormone-releasing hormones in human plasma by means of immunoaffinity purification and LC-HRMS/MS. Anal Bioanal Chem. 2016 May;408(12):3145-53. doi: 10.1007/s00216-016-9377-3. Epub 2016 Feb 15. PubMed PMID: 26879649; PubMed Central PMCID: PMC4830873.

2: Venhuis BJ, Keizers PH, Klausmann R, Hegger I. Operation resistance: A snapshot of falsified antibiotics and biopharmaceutical injectables in Europe. Drug Test Anal. 2016 Mar;8(3-4):398-401. doi: 10.1002/dta.1888. Epub 2015 Oct 12. PubMed PMID: 26456392.